This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Vivo Bio Tech's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹26.711. Vivo Bio Tech's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is ₹0.00.
As of today (2026-06-30), Vivo Bio Tech's share price is ₹23.51. Vivo Bio Tech's Median PS Value is ₹0.00. Therefore, Vivo Bio Tech's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Vivo Bio Tech's Median PS Value or its related term are showing as below:
BOM:511509's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.63 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Vivo Bio Tech (BOM:511509) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Vivo Bio Tech's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
23.51
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivo Bio Tech Median PS Value Related Terms
Vivo Bio Tech Median PS Value Historical Data
* Premium members only.
The historical data trend for Vivo Bio Tech's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:511509 vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, Vivo Bio Tech's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vivo Bio Tech Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vivo Bio Tech's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Vivo Bio Tech's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
Vivo Bio Tech's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹26.711.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivo Bio Tech (BOM:511509) has a Median PS Value of ₹0.00 as of Jun. 30, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Vivo Bio Tech and its competitors. According to the industry distribution chart, Vivo Bio Tech ranks #999999 out of 276 companies in the Biotechnology industry.
Is Vivo Bio Tech's Median PS Value too high?
Vivo Bio Tech's current Median PS Value is ₹0.00. Based on the distribution chart, Vivo Bio Tech ranks #999999 out of 276 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Vivo Bio Tech has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vivo Bio Tech's Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vivo Bio Tech ranks #999999 out of 276 companies for Median PS Value. This places Vivo Bio Tech in the lower half of its industry. The industry median Median PS Value is 0.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.63, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Vivo Bio Tech and its competitors. For the Biotechnology industry, the median Median PS Value is 0.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vivo Bio Tech's current Median PS Value is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivo Bio Tech stock overvalued right now?
Based on GuruFocus' analysis, Vivo Bio Tech (BOM:511509) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹29.55, compared to a current price of ₹23.51 — trading 20.4% below its estimated fair value. The current Median PS Value is ₹0.00. Vivo Bio Tech's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Vivo Bio Tech (BOM:511509), the current Median PS Value is ₹0.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vivo Bio Tech (BOM:511509) Overvalued in 2026?
Based on GuruFocus' analysis, Vivo Bio Tech stock appears to be undervalued.
The current stock price of ₹23.51 is trading 20.4% below its estimated GF Value™ of ₹29.55.
GuruFocus considers Vivo Bio Tech to be Modestly Undervalued.
Key valuation signals for BOM:511509:
Median PS Value: ₹0.00
GF Value™: ₹29.55 vs. price of ₹23.51 (20.4% below fair value)
No single metric tells the full story. See the BOM:511509 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
68GF Score
Get the complete analysis for BOM:511509
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:511509 has been successfully added to your 
